Reneo Pharmaceuticals Inc
NASDAQ:RPHM
Reneo Pharmaceuticals Inc
Cash from Investing Activities
Reneo Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Reneo Pharmaceuticals Inc
NASDAQ:RPHM
|
Cash from Investing Activities
$10.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$27.8B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$4.6B
|
CAGR 3-Years
-89%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-26%
|
See Also
What is Reneo Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
10.5m
USD
Based on the financial report for Dec 31, 2023, Reneo Pharmaceuticals Inc's Cash from Investing Activities amounts to 10.5m USD.
What is Reneo Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
13%
The average annual Cash from Investing Activities growth rates for Reneo Pharmaceuticals Inc have been 13% over the past three years .